Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
13971 | 801 | 41.3 | 91% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
66 | 3 | LEPTIN//ADIPONECTIN//ENDOCRINOLOGY & METABOLISM | 84415 |
1300 | 2 | THIAZOLIDINEDIONES//PPAR GAMMA//ROSIGLITAZONE | 8578 |
13971 | 1 | PRO12ALA POLYMORPHISM//PRO12ALA//PPAR GAMMA 2 | 801 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | PRO12ALA POLYMORPHISM | authKW | 933936 | 3% | 88% | 28 |
2 | PRO12ALA | authKW | 588134 | 2% | 86% | 18 |
3 | PPAR GAMMA 2 | authKW | 542117 | 4% | 44% | 32 |
4 | PPAR GAMMA 2 GENE | authKW | 266841 | 1% | 100% | 7 |
5 | PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2 | authKW | 200534 | 1% | 48% | 11 |
6 | PPAR GAMMA 2 POLYMORPHISM | authKW | 190601 | 1% | 100% | 5 |
7 | PPARG | authKW | 180731 | 3% | 23% | 21 |
8 | PPAR GAMMA GENE | authKW | 169803 | 1% | 64% | 7 |
9 | PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA GENE | authKW | 158832 | 1% | 83% | 5 |
10 | PPAR GAMMA POLYMORPHISM | authKW | 158832 | 1% | 83% | 5 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Endocrinology & Metabolism | 6117 | 34% | 0% | 272 |
2 | Nutrition & Dietetics | 1148 | 10% | 0% | 84 |
3 | Genetics & Heredity | 751 | 14% | 0% | 111 |
4 | Medicine, Research & Experimental | 701 | 12% | 0% | 96 |
5 | Peripheral Vascular Diseases | 140 | 5% | 0% | 37 |
6 | Biochemistry & Molecular Biology | 101 | 14% | 0% | 111 |
7 | Geriatrics & Gerontology | 41 | 1% | 0% | 12 |
8 | Medical Laboratory Technology | 36 | 1% | 0% | 11 |
9 | Cardiac & Cardiovascular System | 33 | 4% | 0% | 31 |
10 | Gastroenterology & Hepatology | 9 | 2% | 0% | 15 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | UNIT GENET BIOL TORS ATHEROSCLEROSIS 05 | 114360 | 0% | 100% | 3 |
2 | DIABET OBES NUTR | 50822 | 0% | 33% | 4 |
3 | ABT ENDOKIRNOL STOFFWECHSEL PATHOBIOCHEM | 38120 | 0% | 100% | 1 |
4 | ABT ENDOKRINOL STOFFWECHSEL PATHOCHEM | 38120 | 0% | 100% | 1 |
5 | ATHESCLEROSIS | 38120 | 0% | 100% | 1 |
6 | BALTIMORE VET MED GERIATR EDUC CLIN | 38120 | 0% | 100% | 1 |
7 | BLIESTAL KLIN | 38120 | 0% | 100% | 1 |
8 | CARDIOVASC STARR | 38120 | 0% | 100% | 1 |
9 | CELLULAR MOL BIOL PATHOL A CALIF DBPCM | 38120 | 0% | 100% | 1 |
10 | CHA BIOMED MED | 38120 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PPAR RESEARCH | 37766 | 3% | 5% | 22 |
2 | JOURNAL OF NUTRIGENETICS AND NUTRIGENOMICS | 7366 | 1% | 3% | 6 |
3 | DIABETES | 5041 | 5% | 0% | 40 |
4 | METABOLISM-CLINICAL AND EXPERIMENTAL | 1527 | 2% | 0% | 19 |
5 | PHARMACOGENETICS | 1440 | 1% | 1% | 6 |
6 | EXPERIMENTAL DIABESITY RESEARCH | 1410 | 0% | 4% | 1 |
7 | GENETIC TESTING AND MOLECULAR BIOMARKERS | 1141 | 1% | 1% | 6 |
8 | MOLECULAR BIOLOGY REPORTS | 1077 | 2% | 0% | 13 |
9 | EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES | 1051 | 1% | 0% | 8 |
10 | DIABETOLOGIA | 1010 | 2% | 0% | 15 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | HE, WM , (2009) PPAR GAMMA 2(PRO12ALA) POLYMORPHISM AND HUMAN HEALTH.PPAR RESEARCH. VOL. . ISSUE . P. - | 149 | 71% | 26 |
2 | HUANG, XA , ZHAO, JP , ZHAO, TF , (2011) EFFECTS OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR-GAMMA 2 GENE PRO12ALA POLYMORPHISM ON FASTING BLOOD LIPIDS: A META-ANALYSIS.ATHEROSCLEROSIS. VOL. 215. ISSUE 1. P. 136 -144 | 66 | 86% | 15 |
3 | LI, Q , CHEN, R , BIE, LZ , ZHAO, DD , HUANG, CK , HONG, J , (2015) ASSOCIATION OF THE VARIANTS IN THE PPARG GENE AND SERUM LIPID LEVELS: A META-ANALYSIS OF 74 STUDIES.JOURNAL OF CELLULAR AND MOLECULAR MEDICINE. VOL. 19. ISSUE 1. P. 198 -209 | 63 | 77% | 4 |
4 | MANSOORI, A , AMINI, M , KOLANDOOZ, F , SEYEDREZAZADEH, E , (2015) OBESITY AND PRO12ALA POLYMORPHISM OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA GENE IN HEALTHY ADULTS: A SYSTEMATIC REVIEW AND META-ANALYSIS.ANNALS OF NUTRITION AND METABOLISM. VOL. 67. ISSUE 2. P. 104 -118 | 61 | 80% | 2 |
5 | OCHOA, MC , RAZQUIN, C , MARTINEZ-GONZALEZ, MA , MARTI, A , MARTINEZ, JA , (2008) ROLE OF PPAR-GAMMA 2 POLYMORPHISMS IN BODYWEIGHT REGULATION.FUTURE LIPIDOLOGY. VOL. 3. ISSUE 1. P. 31-41 | 70 | 84% | 0 |
6 | MEIRHAEGHE, A , AMOUYEL, P , (2004) IMPACT OF GENETIC VARIATION OF PPAR GAMMA IN HUMANS.MOLECULAR GENETICS AND METABOLISM. VOL. 83. ISSUE 1-2. P. 93-102 | 68 | 79% | 87 |
7 | TONJES, A , SCHOLZ, M , LOEFFLER, M , STUMVOLL, M , (2006) ASSOCIATION OF PRO12ALA POLYMORPHISM IN PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA WITH PRE-DIABETIC PHENOTYPES - META-ANALYSIS OF 57 STUDIES ON NONDIABETIC INDIVIDUALS.DIABETES CARE. VOL. 29. ISSUE 11. P. 2489-2497 | 46 | 79% | 110 |
8 | DUJIC, T , BEGO, T , MLINAR, B , SEMIZ, S , MALENICA, M , PRNJAVORAC, B , OSTANEK, B , MARC, J , CAUSEVIC, A , (2014) EFFECTS OF THE PPARG GENE POLYMORPHISMS ON MARKERS OF OBESITY AND THE METABOLIC SYNDROME IN BOSNIAN SUBJECTS.JOURNAL OF MEDICAL BIOCHEMISTRY. VOL. 33. ISSUE 4. P. 323 -332 | 37 | 77% | 2 |
9 | HUGUENIN, GVB , ROSA, G , (2010) THE ALA ALLELE IN THE PPAR-GAMMA 2 GENE IS ASSOCIATED WITH REDUCED RISK OF TYPE 2 DIABETES MELLITUS IN CAUCASIANS AND IMPROVED INSULIN SENSITIVITY IN OVERWEIGHT SUBJECTS.BRITISH JOURNAL OF NUTRITION. VOL. 104. ISSUE 4. P. 488-497 | 37 | 79% | 18 |
10 | TAI, ES , CORELLA, D , DEURENBERG-YAP, M , ADICONIS, X , CHEW, SK , TAN, CE , ORDOVAS, JM , (2004) DIFFERENTIAL EFFECTS OF THE C1431T AND PRO12ALA PPAR GAMMA GENE VARIANTS ON PLASMA LIPIDS AND DIABETES RISK IN AN ASIAN POPULATION.JOURNAL OF LIPID RESEARCH. VOL. 45. ISSUE 4. P. 674-685 | 39 | 81% | 86 |
Classes with closest relation at Level 1 |